Patient response variable (complete response, partial response, non-response) evaluated at 24 weeks. [clinicaltrials_resource:9850a539dad145883acc6b0fb0b2c54f]

Patient response variable (complete response, partial response, non-response) evaluated at 24 weeks. [clinicaltrials_resource:9850a539dad145883acc6b0fb0b2c54f]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:9850a539dad145883acc6b0fb0b2c54f
Study of Epratuzumab in Systemic Lupus Erythematosus [clinicaltrials:NCT00111306]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Patient response variable (complete response, partial response, non-response) evaluated at 24 weeks. [clinicaltrials_resource:9850a539dad145883acc6b0fb0b2c54f]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:9850a539dad145883acc6b0fb0b2c54f
Bio2RDF identifier
9850a539dad145883acc6b0fb0b2c54f
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9850a539dad145883acc6b0fb0b2c54f
measure [clinicaltrials_vocabulary:measure]
Patient response variable (com ...... sponse) evaluated at 24 weeks.
identifier
clinicaltrials_resource:9850a539dad145883acc6b0fb0b2c54f
title
Patient response variable (com ...... sponse) evaluated at 24 weeks.
@en
inDataset
type
label
Patient response variable (com ...... 0a539dad145883acc6b0fb0b2c54f]
@en